Results 171 to 180 of about 746 (183)

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Lancet, The, 2018
Matsatoshi Kudo, Kwang-Hyub Han, Fabio Piscaglia   +2 more
exaly  

Preserving Primary Care: the Front Line in the War Against Cancer

Ca-A Cancer Journal for Clinicians, 2007
exaly  

Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial

Lancet, The, 2019
Stuart R Dalziel, Meredith L Borland, Jeremy S Furyk   +2 more
exaly  

Anal cancer: Current standards in care and recent changes in practice

Ca-A Cancer Journal for Clinicians, 2015
exaly  

Uridylation by TUT4/7 Restricts Retrotransposition of Human LINE-1s

Cell, 2018
Zbigniew Warkocki, Pawel S Krawczyk, Andrzej Dziembowski   +2 more
exaly  

Guidelines for parameters measurement of HVDC transmission line

openaire   +2 more sources

Integrated Wind Turbines and HVDC Power Transmission Lines

IEEE Transactions on Sustainable Energy
Fazel Mohammadi, Nasser Danapour S., Kumars Rouzbehi   +2 more
openaire   +1 more source

Maintenance therapy after first‐line therapy for ovarian cancer: Quantitative effectiveness

Ca-A Cancer Journal for Clinicians
exaly  

Energy harvesting from corona discharge on HVdc overhead transmission line

Electrical Engineering
Liang Gu, Wenfa Ren, Zheng Jiang, Juan He, Xiaoqian Hu, Wei Tan, Xingang Chen   +6 more
openaire   +1 more source

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial

Ca-A Cancer Journal for Clinicians
exaly